Ergomed CRO

Ergomed CRO is the clinical-research business of Ergomed Group, delivering full-service and specialist drug-development support with particular depth in rare disease, oncology and complex trials. Its model combines clinical operations, project management, medical monitoring, regulatory support, pharmacovigilance and study rescue capabilities. The company reports more than 25 years of experience and a team including over 100 MDs and PhDs. Ergomed Group has been privately held by Permira since 2023.